These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23278115)

  • 1. Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk.
    Barbieri RB; Bufalo NE; Cunha LL; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):288-93. PubMed ID: 23278115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility.
    Guilhen AC; Bufalo NE; Morari EC; Leite JL; Assumpcao LV; Tincani AJ; Ward LS
    Clin Cancer Res; 2009 Jan; 15(1):406-12. PubMed ID: 19118072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.
    Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma: long-term outcomes of surgical treatment.
    Abraham DT; Low TH; Messina M; Jackson N; Gill A; Chou AS; Delbridge L; Learoyd D; Robinson BG; Sidhu S; Sywak M
    Ann Surg Oncol; 2011 Jan; 18(1):219-25. PubMed ID: 20878247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
    Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
    Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.
    Barbieri RB; Bufalo NE; Secolin R; Silva AC; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Eur J Endocrinol; 2012 Feb; 166(2):241-5. PubMed ID: 22048975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan.
    Kobayashi M; Otani T; Iwasaki M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Sakamoto H; Yoshida T; Tsugane S
    Scand J Gastroenterol; 2009; 44(8):952-9. PubMed ID: 19452301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
    Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
    Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease.
    Leite JL; Bufalo NE; Santos RB; Romaldini JH; Ward LS
    Eur J Endocrinol; 2010 Feb; 162(2):315-21. PubMed ID: 19903800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
    Manfredi S; Federici C; Picano E; Botto N; Rizza A; Andreassi MG
    Mutat Res; 2007 Aug; 621(1-2):106-12. PubMed ID: 17408703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro.
    Marques CF; Koifman S; Koifman RJ; Boffetta P; Brennan P; Hatagima A
    Oral Oncol; 2006 Jul; 42(6):632-7. PubMed ID: 16488179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetic polymorphisms and ovarian cancer risk.
    Delort L; Chalabi N; Satih S; Rabiau N; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(5B):3079-81. PubMed ID: 19031960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study.
    Moonen HJ; Moonen EJ; Maas L; Dallinga JW; Kleinjans JC; de Kok TM
    Food Chem Toxicol; 2004 Jun; 42(6):869-78. PubMed ID: 15110095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
    Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
    Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.